Abstract: According to one embodiment, an electrolytic apparatus includes an electrolytic cell including a cathode chamber, an intermediate chamber, and an anode chamber, a supply portion which supplies an electrolyte solution to the intermediate chamber, a drain pipe which discharges the electrolyte solution from the intermediate chamber, and a valve in the drain pipe. The supply portion includes a pressure apply portion which applies hydrostatic pressure to the electrolyte solution in the intermediate chamber made static, and which includes a supply pipe, a pump in the supply pipe, and a circulation pipe configured to circulate a part of the electrolyte solution fed from the pump.

Abstract: A compound of formula [I-W]: wherein each symbol is as defined in the description, or a pharmaceutically acceptable salt thereof.

Abstract: According to one embodiment, an electrolytic apparatus includes a diaphragm of a porous membrane having a water permeability of 0.0024 to 0.6 mL/min per cm2 at a differential pressure of 20 kPa, a first electrode provided to oppose the diaphragm, and a second electrode opposing the first electrode via the diaphragm, and the difference between the hydraulic pressures applied onto both sides of the porous membrane is within ±20 kPa.

Abstract: According to one embodiment, an electrolytic water generator includes a plurality of electrolytic cells configured to generate electrolytic water by energizing a pair of electrodes arranged in water to be electrolyzed. An inflow unit is configured to let the water to be electrolyzed flow in parallel. An inflow disconnecting unit is configured to individually disconnect the water to be electrolyzed flowing in parallel is provided in the inflow unit. An electrode disconnecting unit is configured to individually disconnect between the pair of electrodes is provided. Power is supplied with a constant current from a power source by connecting the pair of electrodes of the plurality of electrolytic cells in series through the electrode disconnecting unit.

Abstract: According to one embodiment, a lighting device includes a light source, and at least one light distribution control member configured to control distribution of light from the light source. The light distribution control member includes a base member higher in refractive index than air, and two optical control layers located opposite each other with a predetermined space therebetween on either side of the base member. The two optical control layers each includes a first region and a second region formed in correlative patterns. The light distribution control member is configured to control the light distribution based on a change of an overlap between the first and second regions depending on a direction of transmitted light.

Abstract: A compound of Formula [I] or a pharmaceutically acceptable salt thereof: wherein each symbol is defined as in the specification.

Abstract: According to one embodiment, an electrolytic apparatus includes an electrolytic cell including an anode chamber, an intermediate chamber, a cathode chamber, separating membranes, an anode in the anode chamber, and a cathode in the cathode chamber, a water supply portion which supplies water to the anode and cathode chambers and intermittently changes a water supply and discharge amount, an electrolyte fluid supply portion which supplies and discharges an electrolyte fluid to the intermediate chamber, and a controller which applies potential to the anode and the cathode and electrolyzes the electrolyte fluid in a state where the water supply and discharge amount is small or in a water static state in at least one of the anode and the cathode chambers.

Abstract: According to one embodiment, an electrolytic device includes an electrolytic cell including a first electrode, a second electrode opposing the first electrode and a diaphragm provided between the first electrode and the second electrode. The first electrode is formed of a plate including a first surface opposing the diaphragm, a second surface located on an opposite side to the diaphragm, and first recess portions formed in the first surface with a first pattern. The first recess portions include a bottom surface apart from the first surface and through-holes opening to the second surface of the first electrode and to a part of the bottom surface.

Abstract: According to one embodiment, an electrode unit of an electrolytic device includes a first electrode including a first surface, a second surface located on a side opposite to the first surface, and a plurality of through-holes opening on the first surface and the second surface, a second electrode opposed to the first surface of the first electrode, and a porous membrane containing an inorganic oxide and provided on the first surface of the first electrode to cover the first surface and the through-holes.

Abstract: According to one embodiment, an electrode unit of an electrolytic device includes a first electrode including a first surface, a second surface located on an opposite side to the first surface, a plurality of first pores opened in the first surface, a plurality of second pores opened in the second surface and having an opening area greater than that of the first pores, and a plurality of the first pores communicating with a respective one of the second pores, a second electrode opposing the first surface of the first electrode, and a continuous porous membrane arranged between the first electrode and the second electrode, so as to cover the first surface of the first electrode.

Abstract: The present invention provides a triazolopyridine compound having a prolyl hydroxylase inhibitory action and an erythropoietin production-inducing ability. The present invention relates to a compound represented by the following formula [I]: wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof, or a solvate thereof, as well as a prolyl hydroxylase inhibitor or erythropoietin production-inducing agent containing the compound. The compound of the present invention shows a prolyl hydroxylase inhibitory action and an erythropoietin production-inducing ability and is useful as a prophylactic or therapeutic agent for various diseases and pathologies (disorders) caused by decreased production of erythropoietin.

Abstract: A compound represented by Formula [I]: or pharmaceutically acceptable salt thereof, wherein each symbol is as defined in the description.

Abstract: Provided is an electric riveter including a housing internally provided with a drive unit configured to drive an actuator that withdraws a mandrel from a rivet, and a mandrel collector that collects mandrels. The actuator includes a cover having a proximal end coupled to the housing, a nozzle provided at a distal end of the cover, and a jaw provided in the cover. The drive unit includes an electric motor that drives the actuator. The housing includes a drive housing unit connected to a handle having a rod shape. The electric motor is arranged at a position deviated from the center of grip of the handle in a direction about an axis line extending along the center line of the cover.

Abstract: Provided is an electric riveter including a housing internally provided with a drive unit configured to drive an actuator that withdraws a mandrel from a rivet, and a mandrel collector that collects mandrels. The actuator includes a cover having a proximal end coupled to the housing, a nozzle provided at a distal end of the cover, and a jaw provided in the cover. The drive unit includes an electric motor that drives the actuator. The housing includes a drive housing unit connected to a handle having a rod shape. The electric motor is arranged at a position deviated from the center of grip of the handle in a direction about an axis line extending along the center line of the cover.

Abstract: According to one embodiment, a lighting device includes a base member, a light source on the base member, a light-transmitting cover configured to cover the light source and to emit light emitted from the light source to the outside, and a light guide body provided opposite the light source and configured to guide, to the rear of the light source, at least part of the light from the light source. The cover includes a back light-transmitting region having a plane-normal line directed rearwardly. The light guide body includes a light-incident portion facing the light source and a light guide-emitting portion curvedly extending outward from the light-incident portion, having a distal end portion extending along the back light-transmitting region and directed to the rear.

Abstract: A compound of formula [I-W]: wherein each symbol is as defined in the description, or a pharmaceutically acceptable salt thereof.

Abstract: According to one embodiment, a lighting device includes a light source with a directivity and a light-transmitting cover including a light-transmitting area configured to emit light from the light source to the outside. The light-transmitting cover is in a dome shape and formed of a material doped with scattered fillers dispersed in a volume thereof. The light-transmitting cover includes a vertically elongated shape with an aspect ratio higher than 0.6, and having a transmittance of 70% or less. The aspect ratio is the quotient of a height of the light-transmitting area in an optical axis thereof divided by the width of a rear-end portion of the light-transmitting area.

Abstract: According to one embodiment, a lighting device includes a light source, and at least one light distribution control member configured to control distribution of light from the light source. The light distribution control member includes a base member higher in refractive index than air, and two optical control layers located opposite each other with a predetermined space therebetween on either side of the base member. The two optical control layers each includes a first region and a second region formed in correlative patterns. The light distribution control member is configured to control the light distribution based on a change of an overlap between the first and second regions depending on a direction of transmitted light.

Abstract: According to one embodiment, a lighting device includes a radiation surface, at least one light source provided to face the radiation surface, and an optical control member provided between the radiation surface and the light source and includes optical characteristics of transmission, diffraction, diffusion, and reflection, which vary for regions in the optical control member, a distribution of each of the optical characteristics being determined by positions relative to the at least one light source. The optical control member is formed in a sheet shape which is controlled by at least one of a reflective film having a reflection factor distribution, and a reflective film having a numerical aperture distribution, and lenses.

Abstract: According to one embodiment, a lighting device includes a base member, a light source on the base member, a light-transmitting cover configured to cover the light source and to emit light emitted from the light source to the outside, and a light guide body provided opposite the light source and configured to guide, to the rear of the light source, at least part of the light from the light source. The cover includes a back light-transmitting region having a plane-normal line directed rearwardly. The light guide body includes a light-incident portion facing the light source and a light guide-emitting portion curvedly extending outward from the light-incident portion, having a distal end portion extending along the back light-transmitting region and directed to the rear.